abstract |
(57) Summary The present invention relates to a benzenesulfonamide derivative useful as an active ingredient of a pharmaceutical product. The benzenesulfonamide derivative of the present invention is CCR3 (CC type chemokine. Receptors 3) For the prevention and treatment of diseases with antagonistic activity and related to CCR3 activity, in particular asthma, atopic dermatitis, allergic rhinitis and other inflammatory / It can be used for the treatment of immune diseases. |